Phase 3 data: Zanubrutinib bests standard CLL treatmentAugust 16, 2022CLLMantle Cell LymphomaB Cell Lymphoma
Drug shortages plague hematology, but preparedness helpsJuly 18, 2022CLLB Cell LymphomaMantle Cell Lymphoma
Third-generation Black woman physician makes cancer research historyMay 24, 2022B Cell LymphomaMantle Cell LymphomaCLLDLBCL
Ex–hospital porter a neglected giant of cancer researchMay 11, 2022B Cell LymphomaCLLDLBCLMantle Cell Lymphoma
New trials in lymphoma and MM: Could your patient benefit?November 10, 2021DLBCLMantle Cell LymphomaB Cell Lymphoma
Don’t delay: Cancer patients need both doses of COVID vaccineMarch 15, 2021B Cell LymphomaMantle Cell LymphomaDLBCLCLLFollicular Lymphoma
New inhibitor shows promise in previously failed B-cell malignanciesMarch 12, 2021CLLMantle Cell LymphomaFollicular Lymphoma
Survey quantifies COVID-19’s impact on oncologySeptember 20, 2020DLBCLFollicular LymphomaCLLMantle Cell LymphomaB Cell Lymphoma
